Related Experiment Video
Updated: Dec 22, 2025

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer's Disease
Gabriela Lopes Martins1, Rita Carolina Figueiredo Duarte1, Marat A Mukhamedyarov2
1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Insights
Atrial fibrillation (AF) and Alzheimer's disease (AD) share common inflammatory pathways. Understanding these links may lead to new treatments for both arrhythmia and cognitive decline.
Area of Science:
- Cardiology
- Neurology
- Pathophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to stroke and cognitive decline.
- Alzheimer's disease (AD) is the leading cause of dementia with complex, not fully understood, pathogenesis.
- Inflammation and infection are increasingly implicated in both AD and AF, suggesting a potential common etiology.
Purpose of the Study:
- To elucidate the shared pathophysiological pathways between atrial fibrillation and Alzheimer's disease.
- To identify overlapping predictive biomarkers for both conditions.
- To discuss emerging pharmacological strategies for joint treatment approaches.
Main Methods:
- Review of current literature on the pathophysiology of AF and AD.
- Analysis of shared inflammatory and infectious mechanisms.
- Exploration of potential overlapping biomarkers and therapeutic targets.
Main Results:
- Identification of key shared pathways, including inflammation, linking AF and cognitive decline.
- Highlighting of potential predictive biomarkers common to both conditions.
- Discussion of novel therapeutic strategies targeting these shared pathways.
Conclusions:
- A common link exists between atrial fibrillation and Alzheimer's disease, primarily driven by inflammatory processes.
- Further research into shared biomarkers and joint pharmacological approaches is warranted for effective treatment of both conditions.
Abstract:
Atrial fibrillation (AF) is one of the most prevalent forms of arrhythmia that carries an increased risk of stroke which, in turn, is strongly associated with cognitive decline. The majority of dementia cases are caused by Alzheimer's disease (AD) with obscure pathogenesis. While the exact mechanisms are unknown, the role of inflammatory processes and infectious agents have recently been implicated in both AD and AF, suggesting a common link between these maladies. Here, we present the main shared pathways underlying arrhythmia and memory loss. The overlapping predictive biomarkers and emerging joint pharmacological approaches are also discussed.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Rheumatic Heart Disease I: Introduction
Alzheimer's Disease: Treatment
Atherosclerosis I: Introduction
Inflammation

